3 642

Cited 0 times in

Renal transplantation in sensitized recipients with positive luminex and negative CDC (complement-dependent cytotoxicity) crossmatches

Authors
 Kyu Ha Huh  ;  Myoung Soo Kim  ;  Hae Jin Kim  ;  Dong Jin Joo  ;  Beom Seok Kim  ;  Man Ki Ju  ;  Soon Il Kim  ;  Yu Seun Kim 
Citation
 TRANSPLANT INTERNATIONAL, Vol.25(11) : 1131-1137, 2012 
Journal Title
TRANSPLANT INTERNATIONAL
ISSN
 0934-0874 
Issue Date
2012
MeSH
Adult ; Complement System Proteins/immunology* ; Cytotoxicity Tests, Immunologic/methods ; Cytotoxicity, Immunologic* ; Female ; Graft Rejection/immunology* ; HLA Antigens/immunology ; Humans ; Kidney Transplantation/immunology* ; Kidney Transplantation/physiology ; Living Donors ; Male ; Middle Aged ; T-Lymphocytes/immunology
Keywords
CDC crossmatch ; Luminex-crossmatch ; renaltransplantation.
Abstract
Recently, Luminex-crossmatch (LumXm) was introduced. The aim of this study was to evaluate clinical outcomes in sensitized recipients with a positive Luminex-crossmatch (LumXm (+)) and a negative complement-dependent cytotoxicity crossmatch (CDCXm (-)) after renal transplantation. Fifty-five renal transplant recipients with a CDCXm (-) and PRA class I or II ≥20% were enrolled in this study between February 2008 and December 2010 at Severance Hospital. Eighteen patients displayed LumXm (+) defined as LumXm positive class I or II and 37 patients displayed LumXm (-). Mean duration of follow-up was 18.9 ± 8.3 months. During this period, no patient death or graft loss occurred. The incidence of biopsy-proven or clinically presumed rejection was higher in the LumXm (+) group (n = 12, 66.7%) than in the LumXm (-) group (n = 6, 18.2%) (P = 0.001). All biopsy-proven acute rejections (n = 12) were diagnosed as acute cellular rejection. No significant difference in mean serum creatinine level or eGFR was observed between the groups at 18 months post-transplantation. The short-term outcome of renal transplantation in sensitized patients with a LumXm (+) and a CDCXm (-) may be considered to be acceptable. However, patients with a LumXm (+) have a substantially higher immunological risk for the development of acute cellular rejection.
Full Text
http://onlinelibrary.wiley.com/doi/10.1111/j.1432-2277.2012.01543.x/abstract
DOI
22897830
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Myoung Soo(김명수) ORCID logo https://orcid.org/0000-0002-8975-8381
Kim, Beom Seok(김범석) ORCID logo https://orcid.org/0000-0002-5732-2583
Kim, Soon Il(김순일) ORCID logo https://orcid.org/0000-0002-0783-7538
Kim, Yu Seun(김유선) ORCID logo https://orcid.org/0000-0002-5105-1567
Joo, Dong Jin(주동진) ORCID logo https://orcid.org/0000-0001-8405-1531
Joo, Man Ki(주만기) ORCID logo https://orcid.org/0000-0002-4112-7003
Huh, Kyu Ha(허규하) ORCID logo https://orcid.org/0000-0003-1364-6989
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/91945
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links